Abstract Details
|
Jason H. Margolesky, MD, FAAN
(University of Miami School of Medicine)
PRESENTER |
The institution of Dr. Margolesky has received research support from Parkinson Foundation . |
| Sagari R. Bette, MD (Parkinson's Disease and Movement Disorders Center of Boca Raton) | Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. |
| Danielle S. Shpiner, MD | An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. |
| Tatjana Rundek, MD, PhD | The institution of Dr. Rundek has received research support from NIH. |
| Corneliu C. Luca, MD (University of Miami) | Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. |
| Henry P. Moore, MD (University of Miami - Miller School of Medicine) | Dr. Moore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. |
| Carlos Singer, MD (University of Miami) | Dr. Singer has nothing to disclose. |